Skip to main content
锦好医疗 logo

锦好医疗 — Investor Relations & Filings

Ticker · 920925 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 568 across all filing types
Latest filing 2021-12-23 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920925

About 锦好医疗

https://www.jinghao.cn/

Jinghao Medical specializes in the research, development, and manufacturing of hearing aids and home medical electronic products. The company's core portfolio includes digital and analog hearing aids, medical nebulizers, and electronic blood pressure monitors. It focuses on providing hearing health solutions by integrating advanced digital signal processing technology into its devices. Jinghao Medical operates extensively in the global market, offering original design manufacturing (ODM) and original equipment manufacturing (OEM) services to international partners. The organization emphasizes technological innovation and maintains rigorous quality management systems to comply with international medical device standards. Its primary objective is to deliver accessible, high-performance medical equipment designed to improve the quality of life for users with hearing loss and other chronic health conditions.

Recent filings

Filing Released Lang Actions
承诺管理制度
Regulatory Filings Classification · 95% confidence The document is a formal announcement from Huizhou Jin Hao Medical Technology Co., Ltd. regarding the adoption of a 'Commitment Management System' by the company's board of directors. It includes details about the board meeting date, voting results, and the content of the new internal control system related to commitments and compliance with securities laws and regulations. The document does not contain financial statements, earnings data, or detailed financial analysis. It is not a report like an annual or interim report, nor is it a call transcript or audit report. It is a regulatory announcement about corporate governance and internal control policies, which fits best under Regulatory Filings (RNS). The document length is short (1788 characters), and it is a standalone announcement, not a report publication notice or certification. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2021-12-23 Chinese
关于预计2022年日常性关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the company's expected related party transactions for the year 2022. It includes details about the nature of transactions, parties involved, pricing policies, board approval, and independent director opinions. The document is not a full financial report but a regulatory announcement about anticipated related party dealings. It does not contain financial statements or comprehensive financial analysis. The document length is 2627 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-12-23 Chinese
关于拟修订公司章程公告
Governance Information Classification · 95% confidence The document is a detailed announcement about proposed amendments to the company's Articles of Association (公司章程). It includes specific legal references, detailed clause changes, and governance rules updates. The content is focused on corporate governance structure, board and shareholder meeting procedures, and compliance with listing rules of the Beijing Stock Exchange (北交所). It is not a financial report, earnings release, or audit report. It is not a simple announcement of a report publication but a substantive governance-related document. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2021-12-23 Chinese
监事任命公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the appointment of a new supervisor (监事) at the company 惠州市锦好医疗科技股份有限公司. It details the nomination, voting results, background of the appointee, and the impact of the appointment on the company. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no reference to any report publication. The content clearly relates to changes in the company's board or senior management structure. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and focused solely on management appointment, confirming this classification with high confidence.
2021-12-23 Chinese
募集资金管理办法
Capital/Financing Update Classification · 95% confidence The document is titled '募集资金管理办法' which translates to 'Fundraising Capital Management Measures'. It details the company's internal rules and procedures for managing and using raised funds, including storage, usage, supervision, and changes in use. It references relevant laws and regulations, board and shareholder approvals, and internal controls. The document is a regulatory announcement about the management of fundraising capital rather than a financial report or earnings release. It is not a report publication announcement since it contains substantive content, but it is primarily a governance and procedural document related to capital management. Therefore, the best fitting category is 'Capital/Financing Update' (CAP), as it updates on company fundraising and capital management policies. The document length is under 5,000 characters but contains detailed policy content, not just an announcement of a report publication or a certification. Confidence is high due to clear focus on fundraising capital management rules and procedures.
2021-12-23 Chinese
关于部分在建工程转为投资性房地产及采用成本价值模式计量的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Huizhou Jin Hao Medical Technology Co., Ltd. regarding the reclassification of certain construction-in-progress assets to investment property and the adoption of the cost model for subsequent measurement. It includes details about the assets, board meeting resolutions, and independent director opinions. The document is relatively short (1276 characters) and focuses on a specific accounting treatment change rather than presenting comprehensive financial statements or full audit results. It is not a full annual or interim report, nor is it a certification or a voting result announcement. The content fits best with a regulatory announcement about accounting policy changes and asset reclassification, which aligns with the Regulatory Filings (RNS) category as a fallback for miscellaneous regulatory announcements that do not fit other categories.
2021-12-23 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.